Form 4: Zimmer Biomet CFO Suketu Upadhyay Reports Stock Transactions

Suketu Upadhyay, CFO of Zimmer Biomet Holdings, Inc., reports the vesting of restricted stock units and related transactions.

Summary

• On November 12, 2024, Suketu Upadhyay, the Executive VP and CFO of Zimmer Biomet Holdings, Inc., filed a Form 4 with the SEC.
• The report details transactions involving Zimmer Biomet common stock and restricted stock units (RSUs).
• On November 10, 2024, 15,948 RSUs vested and were converted into common stock.
• Also on November 10, 2024, 7,097 shares were withheld by the company to cover tax obligations related to the vesting of the RSUs at a price of $108.48.
• Upadhyay also acquired 130 shares under the company's Employee Stock Purchase Plan.
• Following these transactions, Upadhyay directly owns 29,745 shares of Zimmer Biomet common stock and no derivative securities.

Sentiment

Score: 6

Explanation: The sentiment is neutral. The filing simply reports stock transactions related to executive compensation. The vesting of RSUs suggests performance targets were met, which is mildly positive.

Positives

• The vesting of RSUs indicates that performance conditions were met, suggesting positive performance within the company.
• Participation in the Employee Stock Purchase Plan shows confidence in the company's future.

Industry Context

Executive stock transactions are a common occurrence in publicly traded companies and are often viewed as a reflection of management's confidence in the company's prospects.

Stakeholder Impact

• The transactions have a minor impact on shareholders as they reflect changes in insider ownership.

Key Dates